Name: UMIN ID:
Unique ID issued by UMIN | UMIN000025579 |
---|---|
Receipt number | R000029437 |
Scientific Title | An exploratory phase II study of neoadjuvant bevacizumab and temozolomide chemotherapy for patients with newly diagnosed malignant glioma |
Date of disclosure of the study information | 2017/01/16 |
Last modified on | 2018/01/09 20:39:20 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/01/09 08:45:31 | ||
2 | Update | 2018/01/09 20:39:20 | Name of primary person or sponsor Co-sponsor Co-sponsor Email1 |